𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutational analysis of the breast cancer susceptibility geneBRIP1/BACH1/FANCJin high-risk non-BRCA1/BRCA2breast cancer families

✍ Scribed by Frédéric Guénard; Yvan Labrie; Geneviève Ouellette; Charles Joly Beauparlant; Jacques Simard; INHERIT BRCAs; Francine Durocher

Book ID
106252331
Publisher
Nature Publishing Group
Year
2008
Tongue
English
Weight
336 KB
Volume
53
Category
Article
ISSN
1435-232X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival of breast cancer patients in BR
Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: A relative survival analysis from Finland
✍ Hannaleena Eerola; Pia Vahteristo; Laura Sarantaus; Pentti Kyyrönen; Seppo Pyrhö 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 69 KB 👁 1 views

Reports on the prognosis of familial breast cancer patients have been contradictory. True differences in survival, if they exist, would have important implications for genetic counselling and in treatment of hereditary breast cancer. We assessed the survival rates of 359 familial breast cancer patie

Cancer predisposing missense and protein
Cancer predisposing missense and protein truncating BARD1 mutations in non-BRCA1 or BRCA2 breast cancer families
✍ Sylvia De Brakeleer; Jacques De Grève; Remy Loris; Nicolas Janin; Willy Lissens; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB 👁 2 views

Fifteen years ago BRCA1 and BRCA2 were reported as high penetrant breast cancer predisposing genes. However, mutations in these genes are found in only a fraction of high risk families. BARD1 is a candidate breast cancer gene, but only a limited number of missense mutations with rather unclear patho

BRCA1 and BRCA2 mutation analysis in bre
BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland
✍ Magdalena Perkowska; Izabela BroŻek; Barbara Wysocka; Karin Haraldsson; Therese 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

Sixty high-risk breast and/or ovarian cancer families from North-Eastern Poland were screened for germline mutations in BRCA1 (MIM# 113705) and BRCA2 (MIM# 600185), using a combination of protein truncation test, denaturing high-performance liquid chromatography and direct sequencing. Sixteen (27%)